|
|
 |
An
important option in the treatment of chronic adult periodontitis. |
|
The
first antimicrobial gel that flows deeply into the periodontal
pockets.
-
Flows to the bottom of pocket, readily adapting to root morphology
- Controlled release of doxycycline for a period of 7 days
- Bioabsorbable- no removal required
- Takes only minutes to prepare and administer
- Solidifies to a wax-like substance in minutes
- Patient friendly - no anesthesia required |
|
Provides
dosing flexibility.
-
Can effectively treat multiple sites with a single syringe.
|
| |
In
clinical trials, ATRIDOX¨ was generally well-tolerated. Side
effects were similar to those of placebo. The most common side
effects were: headache, common cold, gum discomfort, pain or
soreness, toothache, and tooth sensitivity. ATRIDOX¨ should
not be used by patients who are hypersensitive to doxycycline
or any other drugs in the tetracycline class. The use of drugs
in the tetracycline class during tooth development may cause
permanent discoloration of the teeth. Tetracycline drugs, therefore,
should not be used in pregnant women, unless other drugs are
not likely to be effective or are contraindicated.
ATRIDOX® is a registered trademark of TOLMAR, Inc.
ATRIGEL® is a registered trademark of QLT USA, Inc.
|
top
|
|
